Table 2.
Name of drug | Effect on atherosclerosis |
Targeted MSTFs | References |
---|---|---|---|
Statins | ↓ | (+) KLF2; (+) KLF4; (+) NRF2; (−) NF-κB; (−) AP1; (−) YAP/TEAD; (−) HIF-1α | [26, 27, 66, 67, 99-102] |
Resveratrol | ↓ | (+) KLF2; (+) KLF4; (+) NRF2; (−) NF-κB | [22, 68, 69, 103, 104] |
Tannic acid | ↓ | (+) KLF2 | [71, 72] |
SAHA | ↓ | (+) KLF2 | [70] |
Sulforaphane | ↓ | (+) NRF2; (−) NF-κB | [75, 105] |
Verteporfin | ↓ | (−) YAP/TEAD | [77, 78] |
Evodiamine | ↓ | (−) HIF-1α | [79, 106] |
Digoxin | ↓ | (−) HIF-1α | [80, 81] |
2-Methoxyestradiol | ↓ | (−) HIF-1α | [82, 83] |
(+) activate; (−) inhibit.